Krakauer, who holds the John C. Malone Professorship at Johns Hopkins University, has long provided the scientific blueprint for MindMaze. His work at the Brain, Learning, Animation, and Movement Lab focuses on the necessity of high-dose training, a principle that remains central to the company’s digital therapy platform. According to CEO Zach Henderson, the move aims to bridge the gap between academic research and widespread patient access, specifically as the firm establishes its new U.S. base in Charlotte, North Carolina.

The partnership arrives as MindMaze reports positive real-world evidence for its neurorehabilitation tools. Recent internal data points to a 60% increase in daily therapy volume for patients and a 17% improvement in community discharge rates compared to standard care models. By integrating these metrics into a scalable software framework, the company seeks to address the chronic shortage of specialized clinicians available for stroke and Parkinson’s recovery. Krakauer intends to maintain his research focus while actively guiding the deployment of these technologies into home-based and clinical settings.